Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Clinical trial NCT04720105 · COMPLETED
Trial details
- NCT number
- NCT04720105
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2022-03-29
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.